Altre lingue Singular Genomics Systems, Inc.

Azioni

OMIC

US82933R3084

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 09/07/2024			Variaz. 5gg	Var. 1 gen.
7,62 ^USD	-0,39%		-10,46%	-44,79%

24/06	Borsa di Italia: L'Eurozona vuole evitare il suo momento Liz Truss
21/06	Singular Genomics Systems attuerà un frazionamento azionario inverso 1 per 30	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Global markets live: Novo Nordisk, Apple, UPS, Eli Lilly, Qualcomm...	24/06
La zone euro veut éviter son moment Liz Truss	24/06
En Direct des Marchés : Thales, Orange, Safran, Casino, Prosus, Apple, Julius Bär, Hugo Boss...	24/06
Bolsa de Madrid: La eurozona quiere evitar su momento Liz Truss	24/06
Singular Genomics Systems to Implement 1-For-30 Reverse Stock Split	21/06
Singular Genomics Announces 1-for-30 Reverse Stock Split	21/06
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference	29/05
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference	29/05
Similar Genomics Systems: Q1 Earnings Snapshot	14/05
Earnings Flash (OMIC) SINGULAR GENOMICS SYSTEMS Posts Q1 Revenue $0.4M, vs. Street Est of $0.7M	14/05
Singular Genomics Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results	14/05
Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024	01/05
Similar Genomics Systems: Q4 Earnings Snapshot	18/03
Earnings Flash (OMIC) SINGULAR GENOMICS SYSTEMS Posts Q4 Revenue $1.1M, vs. Street Est of $1.04M	18/03
Singular Genomics Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Singular Genomics Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	18/03
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results	18/03
North American Morning Briefing : Investors -2-	18/03
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024	04/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Singular Genomics Systems, Inc.

Azioni

OMIC

US82933R3084

Altre lingue

Filtri